WilmerHale Achieves Trial Victory for Reckitt Benckiser

WilmerHale Achieves Trial Victory for Reckitt Benckiser

Client News

Related Solutions

Providing effective, creative and efficient representation for clients’ most complex commercial disputes.
Clients trust us to protect their most important intellectual property matters.
A global team handling highly complex and sensitive matters in all aspects of litigation.
Battle-tested. Globally Respected.

A WilmerHale team, working closely with lawyers from Sheppard Mullin, secured a major victory for client Reckitt Benckiser following a jury trial in the District of New Jersey. The jury rejected claims brought by Absorption Pharmaceuticals, which sought $454 million in damages for alleged fraud and trade secret misappropriation. Absorption’s claims arose from Reckitt’s 2014-2015 evaluation of a potential transaction involving Absorption’s product Promescent and Reckitt’s 2016 launch of its product K-Y Duration.

The finding of no liability follows over five years of litigation, including multiple COVID-related delays, and testimony from 14 live witnesses during the four-week jury trial.

The WilmerHale team representing Reckitt Benckiser was led by Robert Gunther, Hallie Levin and Peter Neiman and included Jason Liss, Stephanie Lin, Alex Miller and Paul Vanderslice.

 

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel